Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
just voted NO RS
Eli lily just did with Aduro after bmy exit.
I dont think they have enough time left with nasdaq if waiting for data releasing in march. RS and Dilution are inevitaly.
2019 key data will lead partnerships according to Ken!
Here’s your guide to the upcoming biotechnology takeover wave
https://www.marketwatch.com/story/heres-your-guide-to-the-upcoming-biotechnology-takeover-wave-2019-01-15?siteid=yhoof2&yptr=yahoo
Big Pharmas need to see some data first, Let's see the PSA data in the next couple months. It would be a game changer for NEO and HOT. Also data coming first half of 2019. If everything works well according to plan, I do see a buyout coming by end of 2019. Remember AXAL for cervical is $500million Revenue world wide. For sure Advaxis is worth $2-3 billion. the only problem i have is reverse split, also cash problem! Stay tuned! haha
seems like he is going to resign.lol
I really hope Novartis could acquired Aduro this year. I think Aduro and Advaxis are on the same boat right now. the only thing is Aduro got more cash than Advaxis. will join the conference on Tuesday and find out more information about future of Advaxis. I may unload all my shares if things getting ugly.
SEC is closed due to goverment shut down
I didn't see one word about Merck PSA
Seems only 1 patient dosed for solid tumor in ADXS-NEO
this is interesting, Are they runing NEO and HOT under one construct for NSCLC?
Mr. Berlin added, “We are dosing patients under our ADXS-NEO program and anticipate the first patient to be enrolled in our ADXS-503 study within the next several weeks. These are significant accomplishments for the Company and we’re excited to start to see early correlative and safety data from these neoantigen programs during the first half of 2019.”
Found contact and location changed. CMO is in charge
https://clinicaltrials.gov/ct2/history/NCT03265080?V_3=View#StudyPageTop
Clinical trials ADXS-NEO updated today, anything changed?
https://clinicaltrials.gov/ct2/show/study/NCT03265080?term=advaxis&draw=3&rank=1#contacts
The partial shutdown, now in its 19th day with no deal in sight, has sidelined a majority of the workers at the Securities and Exchange Commission. Only 285 of the 4,436 employees are on the job, according to the SEC.
One chinese friend send me this, i couldn't open it, it is in chinese font, what is it?
http://news.sina.com.cn/o/2018-07-27/doc-ihfvkitx7948077.shtml
Clinical trial delayed due to goverment shut down, just heard on CNN last night some FDA department not working.
NEO and HOT are one package deal now.
Somebody is buying all these shares!
Amgen still has Advaxis under (Amgen’s Growing Immunotherapy Arsenal) but took off from (The Shape of Drugs to Come)
https://www.amgenscience.com/features/amgens-growing-immunotherapy-arsenal/
JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says
https://www.fiercepharma.com/pharma/merck-s-big-m-a-dry-spell-isn-t-for-lack-trying-ceo
$1-2billion for Advaxis if data coming strong in March!
“We continue to believe in the strong fundamentals for the biotech space and view the recent significant pullback since October, which erased the past two years of gains, presents an opportunity to add some of the quality biotech names,” Peter Lawson, an analyst with SunTrust Robinson Humphrey, said in a note to clients Monday.
Gilead, Pfizer Execs Suggest Even More Pharma M&A Is On the Way
Be prepared!
https://finance.yahoo.com/news/gilead-pfizer-execs-suggest-even-202748794.html
I have very minimum power, the big sharks are out there! they know which small fish taste good! LOL
In my IRA account, i dont' care that much, stock price is very low, doesn't make sense. i can wait 10-20 years. The science is a bet, the stock is a bet. LOXO was one of my winning bet. AGEN is one of my bet also.
Just bought 300K shares ADXS from my LOXO sale in my IRA acccount, now I can wait another 20 years for advaxis to become a real company.
but we are still a penny stock now. LOL
2 million shares big blocks buy, interesting!
Big Pharma Isn't Boring Any More as Cancer Deals Herald More M&A
Who going to be AMGEN target? who going to be Merck target?
https://finance.yahoo.com/news/big-pharma-isn-apos-t-145954951.html
Soon ONCS will be the best place to work at New Jersy!
look at AXSM
What a Monday morning, look at SAGE! biopharma is on fire beginning of 2019! I have to say it was a show for DAN at Advaxis, bad management team work from beginning!
I have 2000 shares in my IRA account almost two years. i guess don't put your eggs in one basket always make sense.
My classmate was 100% right! Hope Advaxis going to be part of this M&A.
Lilly to buy Loxo Oncology in $8 billion cancer push
https://finance.yahoo.com/news/lilly-buy-loxo-oncology-8-113914089.html
Thank god my LOXO this morning, anything is possible with biotech. Advaxis is next?
who said CC after hours?
Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer
“We believe targeting neoantigens could be the most effective approach for harnessing a person’s immune system to fight cancer,” said James Sabry, M.D., Ph.D., global head of Pharma Partnering, Roche. “This partnership, which combines Adaptive’s pioneering platform for identifying T-cell receptors with Genentech’s cancer immunology expertise, has the potential to change the way cancer is treated and bring us one step closer to truly personalized healthcare.”
https://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechnologies-Enter-Worldwide-Collaboration-License-Agreement
Flex Pharma Finds A Lifeline In Merger With Oncology Biotech Salarius Pharma
is this going to be the option left for Advaxis?
https://finance.yahoo.com/news/flex-pharma-finds-lifeline-merger-152428579.html
Either they don't have website administrator or their IT department just sucks and should get fired!